Public-registry site landscape for NCT06097260, a Idiopathic Pulmonary Fibrosis study sponsored by Pliant Therapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT06097260 (registry record) |
| Sponsor | Pliant Therapeutics, Inc. |
| Condition(s) | Idiopathic Pulmonary Fibrosis |
| Phase | PHASE2 |
| Listed sites | 268 |
| Site countries | United States, Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Czechia, Denmark, France, Germany |
Eichor generates a preliminary site-risk snapshot for NCT06097260 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →